Fatigue is a notable clinical problem in cancer survivors, and understanding its pathophysiology is important. The current study sought to determine biomarkers of fatigue that exist before cancer treatment. Relationships between the expression of latent Epstein-Barr virus (EBV) and cytomegalovirus (CMV) and fatigue were examined in 158 women newly diagnosed with breast cancer or awaiting a positive diagnostic result. Higher CMV antibody titers, but not EBV antibody titers, were associated with a greater likelihood of being fatigued. Associations between fatigue and higher CMV antibody titers remained after controlling for alcohol use, smoking, comorbidities, depressive symptoms, age, BMI, cancer stage, and sleep problems. More sleep problems and higher levels of depressive symptoms were also associated with a greater likelihood of being fatigued. CMV antibody titers, but not EBV antibody titers, were associated with higher levels of C-reactive protein (CRP), but CRP was not associated with fatigue. When the cellular immune system is compromised, reactivation of latent herpesviruses may fuel chronic inflammatory responses. Prior work has suggested that fatigue may be related to inflammation and its associated sickness behaviors; accordingly, our findings may be tapping into this same physiological substrate.
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Introduction
Fatigue is a common problem among those treated for breast cancer, as well as long-term breast cancer survivors (Bower et al., 2006; Butt et al., 2008; Cleeland et al., 2003; Ganz et al., 2002; Jacobsen et al., 2007) . Fatigue adversely affects overall quality of life, as well as many daily activities including mood, the sleepwake cycle, and personal relationships (Bower et al., 2002; Collado-Hidalgo et al., 2006; Lawrence et al., 2004) . Understanding the factors that contribute to fatigue is important. The literature to date has focused on cancer fatigue during and after treatment (Bower, 2007; Jacobsen et al., 1999) . We sought to examine biomarkers of pretreatment fatigue that may be exacerbated by cancer therapies.
Bower and her colleagues have demonstrated that cancer survivors who report persistent fatigue are characterized by higher levels of inflammation after treatment than non-fatigued cancer survivors (Bower, 2007) . For example, fatigued breast cancer survivors had higher levels of proinflammatory activity including interleukin-1 receptor antagonist (IL-1ra), soluble tumor necrosis factor receptor Type II (sTNF-RII), and neopterin than breast cancer survivors who were not fatigued (Bower et al., 2002) . In another study, fatigued survivors had higher levels of soluble IL-1ra and soluble interleukin-6 receptor (sIL-6r) than non-fatigued survivors (Bower et al., 2003) . Similarly, ex vivo production of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-a) by lipopolysaccharide (LPS) stimulated monocytes was higher among fatigued compared to non-fatigued breast cancer survivors (Collado-Hidalgo et al., 2006) .
Maladaptive pretreatment alterations in immune function that promote inflammation could promote subsequent cancer-related fatigue. Recent research has highlighted links between herpesvirus reactivation and inflammation. Herpesviruses create persistent
